Berufsgenossenschaftliche Unfallklinik, Trauma center Murnau, Prof.-Küntscher-Strasse 8, Murnau, Germany.
Arch Orthop Trauma Surg. 2013 Mar;133(3):421-8. doi: 10.1007/s00402-012-1673-6. Epub 2012 Dec 21.
The aim of the study was to identify risk factors of failed two-stage procedures in cases of chronic posttraumatic periprosthetic hip infections.
Between 2006 and 2008, 26 patients with chronic posttraumatic periprosthetic infections after hip arthroplasty were included. In all cases operative bacterial eradication was initiated. The therapy was carried out according to a standardized treatment protocol including the eradication of the bacterial infection and the prosthetic replacement after three negative intra-operative specimens as a two-stage procedure. Follow-up was performed at least 2 years after revision procedure.
Twelve patients showed no signs of infectious recurrence 2 years after prosthetic hip revision therapy (46 %) and were assigned to group I. Group II is constituted by the other 14 patients (54 %). Four of them (16 %) suffered from an infectious recurrence after prosthetic hip replacement, ten patients (38 %) were characterised by a failed bacterial eradication. The spectrum of pathogens showed a significantly higher resistance pattern (p = 0.001) in group II, with a majority of methicillin-resistant Staphylococcus epidermidis (MRSE) and highly resistant Pseudomonas. In addition, patients of group II offered significantly higher American Society of Anesthesiology (ASA) scores (p = 0.015), the body mass index (BMI) was significantly elevated (p = 0.031) and received a significantly higher number of operative procedures (p = 0.016).
A reduced general state of health, a high BMI and highly resistant pathogens are the main risk factors for a failed two-stage procedure after chronic posttraumatic periprosthetic hip infections. Therefore, different treatment strategies are required for a defined subgroup of patients.
本研究旨在确定慢性创伤后髋关节假体周围感染二期手术失败的危险因素。
2006 年至 2008 年期间,共纳入 26 例髋关节置换术后慢性创伤后假体周围感染患者。所有患者均采用手术清除细菌感染。根据标准化治疗方案进行治疗,包括细菌感染的清除和在连续 3 次术中样本阴性后进行假体置换的二期手术。在翻修手术后至少随访 2 年。
12 例患者在髋关节翻修治疗后 2 年无感染复发迹象(46%),归入组 I。组 II 由另外 14 例患者组成(54%)。其中 4 例(16%)在髋关节置换后发生感染复发,10 例(38%)存在细菌清除失败。病原体谱在组 II 中显示出显著更高的耐药模式(p=0.001),以耐甲氧西林表皮葡萄球菌(MRSE)和高度耐药假单胞菌为主。此外,组 II 患者的美国麻醉医师协会(ASA)评分显著升高(p=0.015),体重指数(BMI)显著升高(p=0.031),手术次数显著增加(p=0.016)。
健康状况较差、BMI 较高和高度耐药病原体是慢性创伤后髋关节假体周围感染二期手术失败的主要危险因素。因此,对于特定亚组患者需要采用不同的治疗策略。